Request Sample Inquiry
Active Implantable Devices Market

Active Implantable Devices Market

Active Implantable Devices Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

144

Base Year:

2022

Date

Apr - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1437

Segments Covered
  • By Type By Type Ventricular Assist Devices, Neurostimulators, Implantable Cardiac Pacemakers, Cochlear Implants, Others
  • By End-User By End-User Hospitals & Clinics, Ambulatory Surgical Centers
  • By Region By Region North America, Asia Pacific, Europe, Latin America, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 25.75 Billion
Revenue 2030Revenue 2030: USD 45.24 Billion
Revenue CAGRRevenue CAGR (2023 - 2030): 7.30%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst
Active Implantable Devices Market Share

Market Synopsis:

Global Active Implantable Devices Market valued at USD 25.75 Billion in 2022 and is projected to reach a value of USD 45.24 Billion by 2030 at a CAGR of 7.30% over the forecast period.

The implantable devices market is witnessing significant growth during the forecast period owing to the increasing incidences of cardiovascular and neurological diseases, expanded applications of neurostimulators, and fortunate reimbursement scenario for ENT procedures in the emerging countries. The raising investments and funds to develop the technologically advanced products is also an important factor for the growth of the Active Implantable Devices market during the forecast period. The increased awareness and the upsurge in the applications of neurostimulators are further expected to contribute to the growth of Active Implantable Devices market in the coming years. Furthermore, the favorable reimbursement scenario for the ENT procedures in developed countries is projected to fuel the growth of the Active Implantable Devices market during the forecast period. However, the unfavorable healthcare modifications in the United States associated with the use of implantable medical devices, and the increased cost of implants is likely to hamper the growth of Active Implantable Devices market to a certain level during the forecast period. Whereas, increasing adoption of Active Implantable Devices in the emerging markets and the growth of subcutaneous implantable cardioverter defibrillators (S-ICD’s) are expected to provide growth opportunities for the growth of the market in coming years.

Active Implantable Devices Market Size, 2022 To 2030 (USD Billion)

AI (GPT) is here !!! Ask questions about Active Implantable Devices Market
Loading....

Market Segmentation:

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

  • Real-Time Data Updates:
  • Competitor Benchmarking
  • Market Trends Heatmap
  • Custom Research Queries
  • Market Sentiment Analysis
  • Demographic and Geographic Insights

Get Access Now

The Hospital End User is Projected to Dominate the Market During the Forecast Period

Based on end-user, the hospital segment is expected to dominate the Active Implantable Devices market during the forecast period. The growth of hospital segment is due to the presence of large patient pool in the hospital owing to the cardiovascular and neurological diseases, and increasing geriatric population globally. The growth in innovative technologies in the hospitals is also expected to fuel the growth of the hospital segment in the Active Implantable Devices market in the coming years.

North America Region Accounted for the Largest Share of the Global Active Implantable Devices Market

North America acquired the largest share of the Active Implantable Devices market in 2021. The growth of the North America is mainly attributed to the increasing in the geriatric population, increasing occurrence of cardiovascular and neurological diseases, and increase in the healthcare expenditure in the North America region. Moreover, the development of new products and the various innovations are predicted to fast-track the growth of the North America market in the coming years. The major players in the market are expected to concentrate on research and development activity in order to enhance their position in the Active Implantable Devices market in the coming years.

Asia Pacific is accounted to mention the fastest growth in the Active Implantable Devices market during the forecast period. The growth in the Asia-Pacific region can be mainly attributed to the increase in geriatric population, healthcare reforms for infrastructural development, growing frequency of chronic diseases, rising healthcare spending, rising demand for innovative technologies to develop innovative products, and minimum strict regulations.

Order Now Get Free Sample Customize Report

Competitive Landscape:

The key major players in the market are projected to focus on the research and development activity to enhance their market position in the Active Implantable Devices market in coming years. The key players in the global Active Implantable Devices market are making prominent efforts to launch new cost-effective products in order to generate opportunities in developing economies. some of the key-players in the market are Sonova Holding AG, Medtronic, Abbott, Lifetech Scientific, Boston Scientific Corporation, Cochlear Ltd., MED-EL, Biotronik SE & CO. KG, LivaNova PLC, Advanced Bionics AG.

Active Implantable Devices Market is Segmented as Follows:

Parameter Details
Segments Covered

By Type

  • Ventricular Assist Devices
  • Neurostimulators
  • Implantable Cardiac Pacemakers
  • Cochlear Implants
  • Others

By End-User

  • Hospitals & Clinics
  • Ambulatory Surgical Centers

By Region

  • North America
  • Asia Pacific
  • Europe
  • Latin America
  • Middle East & Africa

Regions & Countries Covered
  • North America - (U.S., Canada, Mexico)
  • Europe - (U.K., France, Germany, Italy, Spain, Rest Of Europe)
  • Asia Pacific - (China, Japan, India, South Korea, South East Asia, Rest Of Asia Pacific)
  • Latin America - (Brazil, Argentina, Rest Of Latin America)
  • Middle East & Africa - (GCC Countries, South Africa, Rest Of Middle East & Africa)
Companies Covered
  • Sonova Holding AG
  • Medtronic
  • Abbott
  • Lifetech Scientific
  • Boston Scientific Corporation
  • Cochlear Ltd.
  • MED-EL
  • Biotronik SE & CO. KG
  • LivaNova PLC
  • Advanced Bionics AG
Report Coverage Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis
Pricing and purchase options Avail of customized purchase options to meet your exact research needs. Explore purchase options

Active Implantable Devices Market is Tabulated as Follows:

FAQ
Frequently Asked Question
  • The global Active Implantable Devices valued at USD 25.75 Billion in 2022 and is expected to reach USD 45.24 Billion in 2030 growing at a CAGR of 7.30%.

  • The prominent players in the market are Sonova Holding AG, Medtronic, Abbott, Lifetech Scientific, Boston Scientific Corporation, Cochlear Ltd., MED-EL, Biotronik SE & CO. KG, LivaNova PLC, Advanced Bionics AG.

  • The market is project to grow at a CAGR of 7.30% between 2023 and 2030.

  • The driving factors of the Active Implantable Devices include

    • Increasing Burden of Cardiovascular Diseases

  • North America was the leading regional segment of the Active Implantable Devices in 2022.